Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02061774 · ClinicalTrials.gov registry record · Phase 4

Postoperative Opioid Use and Pain Scores in Patients Undergoing Transforaminal Lumbar Interbody Fusion

A Phase 4 study, sponsored by Texas Tech University Health Sciences Center.

Terminated
Registry status
Phase 4
Development phase
21
Enrollment target

NCT02061774 is a Phase 4 study that was terminated before completion, run by Texas Tech University Health Sciences Center. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02061774, a Phase 4 study, was terminated before completion, sponsored by Texas Tech University Health Sciences Center.

TERMINATED
Registry status
Phase 4
Development phase
21 participants
Enrollment target

Study Summary

The purpose of this project is to study the effects of preoperative followed by scheduled intravenous acetaminophen on pain control for 24 hours postoperatively after minimally invasive 1 or 2 level transforaminal lumbar interbody fusion.

Interventions

  • DRUG Acetaminophen
  • DRUG Placebo comparator

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2013-10
Est. Completion 2018-01-11
Phase Phase 4

What the Registry Record Tells You About NCT02061774

The ClinicalTrials.gov registry entry for NCT02061774 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.

NCT02061774 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02061774 about?

NCT02061774 is a clinical study titled "Postoperative Opioid Use and Pain Scores in Patients Undergoing Transforaminal Lumbar Interbody Fusion". The purpose of this project is to study the effects of preoperative followed by scheduled intravenous acetaminophen on pain control for 24 hours postoperatively after minimally invasive 1 or 2 level transforaminal lumbar interbody fusion.

What is the current status of trial NCT02061774?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2013-10. Estimated completion is 2018-01-11.

What interventions are being tested in trial NCT02061774?

The interventions under investigation include: Acetaminophen (DRUG), Placebo comparator (DRUG).

Who is sponsoring clinical trial NCT02061774?

This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.